{"id":"W1995328364","doi":"10.1517/14712590802666397","title":"Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Aflibercept; Angiogenesis; Cancer research; Decoy; Vascular endothelial growth factor; Tyrosine kinase; Receptor tyrosine kinase; Metastasis; Medicine; Cancer; VEGF receptors; Receptor; Internal medicine; Bevacizumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002861078,0.0008960923,0.001286273,0.00009324139,0.0002164345,0.00007183234,0.0006261481,0.001000873,0.0001027811],"category_scores_gemma":[0.0000642723,0.0005780593,0.001608199,0.0001315993,0.0001258879,0.00000928504,0.00006027184,0.0001690717,0.000008161878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007093072,"about_ca_system_score_gemma":0.0001081658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003315198,"about_ca_topic_score_gemma":0.000001072034,"domain_scores_codex":[0.9967602,0.0004702854,0.0006393617,0.001303036,0.0002240576,0.0006030785],"domain_scores_gemma":[0.9987187,0.0001238051,0.0003948011,0.0004271523,0.000114771,0.0002208074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001728555,0.0003703308,0.000009056844,0.0000440548,0.0003945932,0.000001227363,0.00003635725,0.000004437164,0.01403397,0.0001533509,0.004136033,0.9806437],"study_design_scores_gemma":[0.0006678401,0.003263805,0.00001275557,0.0003331696,0.000005375784,0.000004433857,0.00004886628,0.000003045086,0.01566854,0.00006003549,0.9791225,0.0008096979],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002010559,0.9947994,0.0005767199,0.00002565904,0.0004478854,0.001204837,0.0007663298,0.00005408183,0.0001145355],"genre_scores_gemma":[0.002038328,0.9887388,0.000178932,0.0006835135,0.002755786,0.0004712324,0.004982376,0.0001097991,0.00004127942],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.979834,"threshold_uncertainty_score":0.9996671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1281319538255109,"score_gpt":0.3852148239328217,"score_spread":0.2570828701073108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}